EP3167282A1 - Analyte concentration measurement - Google Patents
Analyte concentration measurementInfo
- Publication number
- EP3167282A1 EP3167282A1 EP15747510.4A EP15747510A EP3167282A1 EP 3167282 A1 EP3167282 A1 EP 3167282A1 EP 15747510 A EP15747510 A EP 15747510A EP 3167282 A1 EP3167282 A1 EP 3167282A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- potential
- cycle
- mediator
- concentration
- test meter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000005259 measurement Methods 0.000 title claims abstract description 30
- 239000012491 analyte Substances 0.000 title claims abstract description 21
- 238000009825 accumulation Methods 0.000 claims abstract description 31
- 238000006479 redox reaction Methods 0.000 claims abstract description 31
- 238000000034 method Methods 0.000 claims abstract description 28
- 239000008364 bulk solution Substances 0.000 claims abstract description 13
- 230000007423 decrease Effects 0.000 claims abstract description 11
- 238000012360 testing method Methods 0.000 claims description 31
- 230000003647 oxidation Effects 0.000 claims description 24
- 238000007254 oxidation reaction Methods 0.000 claims description 24
- 230000009467 reduction Effects 0.000 claims description 22
- 230000000977 initiatory effect Effects 0.000 claims description 17
- 238000009792 diffusion process Methods 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 7
- 230000002452 interceptive effect Effects 0.000 abstract description 3
- 238000005534 hematocrit Methods 0.000 abstract description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 19
- 239000008103 glucose Substances 0.000 description 19
- 238000006243 chemical reaction Methods 0.000 description 14
- 230000035945 sensitivity Effects 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 230000000116 mitigating effect Effects 0.000 description 7
- 238000013459 approach Methods 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000000840 electrochemical analysis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000011946 reduction process Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
- G01N27/3274—Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration
Definitions
- the present invention relates to a diffusion based analyte concentration measurement that mitigates the effects of diffusion interfering factors.
- Electrochemical-based sensors such as self-monitoring blood glucose (SMBG) strips, are used for measuring/determining analyte concentration in fluid samples, for example whole blood.
- DIF diffusion interfering factors
- Hct blood haematocrit
- DIF mitigation can be categorized into active approaches and passive approaches.
- the former relies on using DIF sensitive signals to have DIF "measurements" which are then used for DIF correction.
- a problem with active approaches is that they require extra mechanisms, such as additional strip elements, more measurement steps, and additional device/meter components/parts.
- passive approaches use DIF insensitive signals or signals with negligible DIF effect for the analyte measurement.
- US8105478B2 describes a method for selecting pulse lengths for measuring the concentration of a redox-active substance as a mediator in a molecular-biological detection system, in which suitable potentials are applied to a working electrode, to cause at least one of an oxidation process and a reduction process, which takes place as a redox reaction.
- the method comprises pulsing the potential of the working electrode and alternately forming measuring phases and relaxation phases; selecting the measuring-phase pulse lengths so that, towards the end of the pulse, the capacitive current is relatively small in comparison with the Faraday current; and selecting the relaxation-phase pulse lengths so that, towards the end of the pulse, the concentration gradient is relaxed so that at the beginning of a following measuring phase, the change in concentration of the mediator, brought about by the consumption of the mediator by the measurement itself, is reversed to the greatest possible extent approaching the original level.
- the concentration gradient may gradually and continuously decrease towards the bulk solution.
- the concentration gradient may fluctuate, whilst generally decreasing towards the bulk solution.
- the at least one electrode may be coated with at least one redox mediator.
- the electrode may be in a solution that includes at least one redox mediator, and so is exposed to the at least one redox mediator.
- the accumulation phase can have a reduction at the working electrode and the measurement phase can have an oxidation at the working electrode.
- the accumulation phase may have an oxidation and the measurement phase can have a reduction at the working electrode depending on nature of redox reaction involving the analyte and mediator(s). As is known in the art, whether the accumulation phase should have reduction or oxidation depends on the mediator state (oxidised or reduced) before it undergoes the heterogeneous reaction at electrode surface. Also, it will be appreciated that more than one mediator may be used for a series of redox reactions.
- further potentials may be applied to the electrode(s). Such further potentials could be applied before the first potential or after the second potential.
- an initiation potential may be applied prior to applying the at least one cycle of pulses, wherein the initiation potential has an open circuit or potential for substantially no redox reaction at the electrodes.
- the initiation potential may be applied prior to applying each cycle of pulses.
- the second potential has to immediately follow the first potential, so that the accumulation phase that forces accumulation of the concentration gradient immediately precedes the measurement phase.
- the second potential is such that after depletion of the established concentration gradient of the mediator another concentration gradient of the mediator builds up (the opposite concentration gradient is established), but with a concentration that increases towards the bulk solution.
- the magnitudes of the first potential and the second potential may be symmetrical relative to a potential which elicits substantially zero current flow (E 0) .
- the magnitudes of the first potential and second potential may be asymmetrical to E 0 .
- Durations of the first potential and the second potential may be the same. Durations of the first potential and the second potential may be different. Durations of the first potential and the second potential may be less than 10 minutes, preferably less than 1 minute, and most preferably less than 5 seconds. Durations of the first potential and the second potential may be between 5 to 100% of the total time of each pulse cycle.
- a test meter for determining analyte concentration using a redox reaction in an electrochemical cell that has at least two electrodes, one of which is a working electrode, at least one electrode exposed to at least a redox mediator, using at least one cycle of pulses, each cycle having a first potential and a second potential, the meter being configured to: apply a first potential to initiate an accumulation phase that forces accumulation of a concentration gradient of the mediator at or close to the working electrode with a concentration that decreases towards the bulk solution; apply a second potential to initiate a measurement phase and deplete the established concentration gradient of the mediator; and measure current associated with the second potential of each cycle.
- the test meter is configured to calculate analyte concentration using the measured current.
- the accumulation phase can be a reduction and the measurement phase can be an oxidation.
- the accumulation phase can be an oxidation and the measurement phase can be a reduction depending on the nature of the redox reaction involving the analyte and mediator(s). Also, it will be appreciated that more than one mediator may be used for a series of redox reactions.
- the second potential may be such that after depletion of the established concentration gradient of the mediator another concentration gradient of the mediator builds up, but with a concentration that increases towards the bulk solution.
- the magnitudes of the first potential and the second potential may be symmetrical relative to a potential that causes substantially zero current flow (E 0 ).
- the magnitudes of the first potential and second potential may be asymmetrical to E 0 .
- Durations of the first potential and the second potential may be the same. Durations of the first potential and the second potential may be different. Durations of the first potential and the second potential may be less than 10 minutes, preferably less than 1 minute, and most preferably less than 5 seconds. Durations of the first potential and the second potential may be between 5 to 100% of the total time for each pulse cycle.
- Figure 1 shows switching redox reactions at two electrodes by controlling potential
- Figure 2 shows an evolution of M red (reduced mediator) concentration gradient at the working electrode E1 with the redox reaction switch in Figure 1 ;
- Figure 3 shows a test waveform and a control waveform for applying to the electrodes of an electrochemical cell
- Figure 4 shows current sensitivity to glucose versus measurement time for various samples taken using the waveforms of Figure 3, where the numbers in the legends are Hct levels as a percentage, and
- Figure 5 shows the percentage biases to the nominal Hct of current sensitivity to glucose at 0.3 seconds of four of the oxidation pulses of the waveforms of Figure 3, where the numbers in legends are the pulse numbers of the waveforms in Figure 3.
- This present invention mitigates the effects of DIF current signals by switching and controlling redox reactions at the working and counter electrodes of electrochemical- based sensors that use mediators. This is done by creating a higher concentration of mediator near the working electrode than in the bulk sample during an accumulation phase, so that a mediator concentration gradient is present at the start of each measurement phase.
- the mediator concentration gradient extends by at least 10nm from the working electrode into the bulk sample.
- the mediator concentration gradient should not reach the counter electrode, and so ideally the maximum extent of the mediator gradient is less than the separation of the working and counter electrodes. In many practical implementations, it is preferred that by the end of the accumulation phase and the start of the measurement phase, the mediator concentration gradient does not extend to beyond half way between the working and counter electrodes.
- Figure 1 shows one pulse cycle and the initiated corresponding redox reactions of an electrochemical test strip with two electrodes, a working electrode E1 and a counter electrode E2.
- the two electrodes are covered with a reagent layer which contains redox mediator (M) and enzyme (Enz).
- M redox mediator
- Enz enzyme
- the working and counter electrodes E1 and E2 respectively are in contact with a whole blood sample and an electrical potential (voltage) is applied between the two electrodes. This results in redox reactions both in the blood (homogeneous redox reactions) and at surfaces of the two electrodes (heterogeneous redox reactions).
- E red reduction potential
- E ox oxidation potential
- E red bias (difference) to E 0 and E ox bias to E 0 can be the same (i.e. symmetrical to E 0 as illustrated in Figure 1 ) or different.
- oxidized mediator (M ox ) undertakes reduction at the working electrode E1 (reaction 3), whilst reduced mediator (M red ) undertakes oxidation at the counter electrode E2 (reaction 2).
- glucose (Glue) reacts with M ox involving the enzyme (Enz) to produce M red in blood (reaction 1 ).
- M red is "accumulated" at the working electrode E1 (both reactions 1 and 3 produce M red ) to a concentration C, higher than the starting M red concentration C 0 and a M red concentration gradient is established with decreasing M red concentration from the working electrode E1 surface towards the bulk solution (see Figure 2A to 2B).
- the heterogeneous redox reactions at the two electrodes are switched over (see Figure 1 ).
- glucose concentration is determined by measuring the rate of reaction 5, e.g. by measuring current.
- Rate of reaction 5 is proportional to M red available at the surface of the working electrode E1 .
- Reaction 5 proceeds at a sufficiently high rate to cause M red depletion to be faster than its supply (through diffusion) at the surface of the working electrode E1 .
- M red concentration drops from , through C 0 , ultimately to C zero (see the dotted concentration gradient line in Figure 2C) with time.
- C g is negative and the rate of reaction 5 decreases with time in a pattern described by the Cottrell equation (see below), and the glucose measurement is Hct dependent.
- the rate of reaction 5 is dependent on M red diffusion and the M red concentration gradient established during the previous reduction pulse.
- Increasing Hct decreases M red diffusion, but increases the M red concentration gradient. Therefore, the Hct effect on the glucose measurement is compensated by manipulating the redox reaction switch.
- the current has to be measured in the concentration gradient depletion phase only, i.e. while the concentration gradient is being depleted. After the depletion phase, when the mediator concentration drops below its start level (i.e. the level prior to the accumulation phase), the current becomes Hct dependent.
- Establishment of the M red concentration gradient during the accumulation phase can be achieved in various ways, including, but not limited to, controlling the potential magnitude and/or polarity of the pulses applied, controlling the effective surface ratio of the two electrodes, controlling the pulse time, controlling reagent layer components and quantity ratios, or any combination of these.
- the potential magnitude of the pulses applied is used to force accumulation of the mediator concentration gradient and subsequently deplete the established mediator concentration gradient at the working electrode.
- other techniques for controlling the accumulation and depletion of mediator concentration are possible.
- Figure 3 shows a control waveform W69 and test waveform W70.
- the difference between the test waveform W70 and the control waveform W69 is that the test waveform W70 has a higher potential magnitude for the reduction pulses (pulses 2, 4, 6, 8) than the control waveform W69 to enhance the establishment of M red concentration gradient at the working electrode E1 during these pulses (see Figure 1 ).
- Both the oxidation and reduction pulses of the test waveform are over-potential. By this it is meant that the potential is of a magnitude that is sufficient for the redox reactions at the electrodes to be dominated by diffusion of the mediator and/or analyte towards the electrode. Magnitudes of the oxidation and reduction pulses are selected and controlled by taking into account the electrochemical properties of the mediator and the electrodes. Both the oxidation and reduction pulses can have positive, negative or zero potentials.
- Pulse 1 is an initiation pulse that is applied once before the start of the repeated cycles of pulses (i.e. it is not part of the repeated cycle of pulses).
- Pulse 1 is an under-potential pulse wherein the rate of redox reactions at the electrodes is dominated by the kinetics of the heterogeneous redox reactions to allow hydration/dissolution of the strip reagent layer (potential of this pulse can be E 0 or close to E 0 to keep redox reaction at both the working electrode E1 and the counter electrode E2 to a minimum). Pulse 1 can also be an open circuit.
- the total test time of the 9 pulses in this experiment was designed for 6.25 seconds, but the test can be completed in 5 seconds (i.e. without pulses 8 and 9) or less.
- the waveforms were applied to the strip using a potentiostat, so that a positive potential lead to oxidation and a negative/zero potential leads to reduction at the working electrode E1 .
- the oxidation current i.e. positive pulse current resulting from reaction 5 in Figure 1
- Techniques for determining glucose concentration using current measured during a redox reaction are well known in the art and so will not be described in detail.
- FIG. 4 shows that in each graph of W69, there are clear separations between the lines of positive pulses (measuring pulses). Higher Hct corresponds to lower current sensitivity. This indicates that W69 measuring currents are sensitive to Hct variation. In contrast, for the graphs of W70, the line separation disappears or is remarkably decreased, i.e. Hct as a DIF is effectively accounted for. W70 leads to significantly higher current sensitivity than W69, i.e. W70 has enhanced current sensitivity to glucose compared to W69.
- W70 lines in Figure 4 have higher magnitude than W69 lines; 2) W70 lines of each pulse have similar/close magnitude (they are on top of each other if overlaid) whilst W69 lines of each pulse decreases with time, i.e. W70 retains current sensitivity throughout the test time whilst W69 does not. This is because the established M red concentration gradient during the reduction pulse leads to enhanced reaction 5 of the subsequent oxidation pulse.
- Figure 5 also show the mitigation of Hct, where percentage bias is the difference in current sensitivity between the Hct of interest and the nominal Hct (defined here as 42%, and so this has zero bias).
- percentage bias is the difference in current sensitivity between the Hct of interest and the nominal Hct (defined here as 42%, and so this has zero bias).
- the current sensitivity at 0.3 seconds of the oxidation pulses 3, 5, 7 and 9 are used.
- the bias to nominal Hct had a range of about 20% to -20% with increased Hct.
- the bias to nominal Hct was reduced with a range less than +/-10%.
- DIF mitigation and in particular Hct mitigation
- Hct mitigation can be achieved by other means. For example, this could be done by increasing the effective surface ratio of the counter electrode E2 to the working electrode E1 , or increasing the duration of the accumulation phase pulses.
- any technique that forces the accumulation of a concentration gradient of the mediator at the working electrode E1 could be used.
- the present invention provides a simple and effective technique for mitigating the effects of DIF providing an Hct insensitive measurement.
- the method could be applied to existing products without making any changes to the strips.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Electrochemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1412156.0A GB201412156D0 (en) | 2014-07-08 | 2014-07-08 | Analyte concentration measurement |
PCT/GB2015/051973 WO2016005743A1 (en) | 2014-07-08 | 2015-07-08 | Analyte concentration measurement |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3167282A1 true EP3167282A1 (en) | 2017-05-17 |
Family
ID=51410820
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP15747510.4A Withdrawn EP3167282A1 (en) | 2014-07-08 | 2015-07-08 | Analyte concentration measurement |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP3167282A1 (en) |
JP (1) | JP6619367B2 (en) |
KR (1) | KR20170028408A (en) |
CN (1) | CN106687803A (en) |
AU (1) | AU2015287447A1 (en) |
BR (1) | BR112017000305A2 (en) |
CA (1) | CA2953452A1 (en) |
GB (1) | GB201412156D0 (en) |
RU (1) | RU2680266C2 (en) |
WO (1) | WO2016005743A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017035393A1 (en) | 2015-08-25 | 2017-03-02 | eSense, LLC | Devices, systems and methods for detecting viable microorganisms in a fluid sample |
US10174356B2 (en) | 2016-05-31 | 2019-01-08 | Avails Medical, Inc. | Devices, systems and methods to detect viable infectious agents in a fluid sample and susceptibility of infectious agents to anti-infectives |
US20180306744A1 (en) * | 2017-04-20 | 2018-10-25 | Lifescan Scotland Limited | Analyte measurement system and method |
WO2019005296A1 (en) | 2017-06-27 | 2019-01-03 | Avails Medical, Inc. | Apparatus, systems, and methods for determining susceptibility of microorganisms to anti-infectives |
WO2019070739A1 (en) * | 2017-10-03 | 2019-04-11 | Avails Medical, Inc. | Apparatus, systems, and methods for determining the concentration of microorganisms and the susceptibility of microorganisms to anti-infectives based on redox reactions |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090184004A1 (en) * | 2008-01-17 | 2009-07-23 | Lifescan, Inc. | System and method for measuring an analyte in a sample |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7455975B2 (en) * | 2000-04-14 | 2008-11-25 | Esa Biosciences, Inc. | Electrochemical detection of nucleic acid sequences |
RU2267120C2 (en) * | 2000-07-14 | 2005-12-27 | Лайфскен, Инк. | Electrochemical mode of measuring of speed of chemical reactions |
GB0211449D0 (en) * | 2002-05-17 | 2002-06-26 | Oxford Biosensors Ltd | Analyte measurement |
GB2428484B (en) * | 2004-01-29 | 2008-09-10 | Siemens Ag | Method for measuring the concentration or change in concentration of a redox-active substance and associated device |
WO2005114164A2 (en) * | 2004-05-14 | 2005-12-01 | Bayer Healthcare Llc | Voltammetric systems for assaying biological analytes |
US7749371B2 (en) * | 2005-09-30 | 2010-07-06 | Lifescan, Inc. | Method and apparatus for rapid electrochemical analysis |
EP2082222B1 (en) * | 2006-10-05 | 2012-11-21 | Lifescan Scotland Limited | Systems and methods for determining a substantially hematocrit independent analyte concentration |
JP5889893B2 (en) * | 2010-07-19 | 2016-03-22 | シラグ・ゲーエムベーハー・インターナショナルCilag GMBH International | System and method for measuring an analyte in a sample |
US9201038B2 (en) * | 2012-07-24 | 2015-12-01 | Lifescan Scotland Limited | System and methods to account for interferents in a glucose biosensor |
US9005426B2 (en) * | 2012-09-28 | 2015-04-14 | Cilag Gmbh International | System and method for determining hematocrit insensitive glucose concentration |
GB2515299B (en) * | 2013-06-18 | 2015-12-30 | Suresensors Ltd | Methods and apparatus for determining analyte in a sample |
-
2014
- 2014-07-08 GB GBGB1412156.0A patent/GB201412156D0/en not_active Ceased
-
2015
- 2015-07-08 EP EP15747510.4A patent/EP3167282A1/en not_active Withdrawn
- 2015-07-08 WO PCT/GB2015/051973 patent/WO2016005743A1/en active Application Filing
- 2015-07-08 AU AU2015287447A patent/AU2015287447A1/en not_active Abandoned
- 2015-07-08 JP JP2016573879A patent/JP6619367B2/en not_active Expired - Fee Related
- 2015-07-08 BR BR112017000305A patent/BR112017000305A2/en not_active Application Discontinuation
- 2015-07-08 CA CA2953452A patent/CA2953452A1/en not_active Abandoned
- 2015-07-08 CN CN201580037065.6A patent/CN106687803A/en active Pending
- 2015-07-08 KR KR1020177003207A patent/KR20170028408A/en unknown
- 2015-07-08 RU RU2017103730A patent/RU2680266C2/en not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090184004A1 (en) * | 2008-01-17 | 2009-07-23 | Lifescan, Inc. | System and method for measuring an analyte in a sample |
Also Published As
Publication number | Publication date |
---|---|
WO2016005743A1 (en) | 2016-01-14 |
RU2017103730A3 (en) | 2019-01-14 |
BR112017000305A2 (en) | 2017-10-31 |
CA2953452A1 (en) | 2016-01-14 |
JP2017519990A (en) | 2017-07-20 |
RU2017103730A (en) | 2018-08-08 |
JP6619367B2 (en) | 2019-12-11 |
AU2015287447A1 (en) | 2016-12-22 |
RU2680266C2 (en) | 2019-02-19 |
CN106687803A (en) | 2017-05-17 |
GB201412156D0 (en) | 2014-08-20 |
KR20170028408A (en) | 2017-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10908112B2 (en) | Rapid-read gated amperometry devices | |
RU2262890C2 (en) | Electrochemical method and devices usable for determining concentration of substances under study with correction on hematocrit number | |
WO2016005743A1 (en) | Analyte concentration measurement | |
EP2016399B1 (en) | Method for determining underfill in an electrochemical biosensor and underfill detection system | |
CN106940341B (en) | For detecting the system and method for sensor for using and drying out | |
RU2647473C2 (en) | Systems and methods for improved stability of electrochemical sensors | |
JP2008536139A (en) | Determination of partial filling in electrochemical specimens | |
EP3011323B1 (en) | Methods and apparatus for determining analyte in a sample using a sensor having electrodes which are provided with an enzyme and a mediator | |
MX2012014281A (en) | Underfill management system for a biosensor. | |
KR20130026528A (en) | System and method for determining the concentration of an analyte in a sample fluid | |
JP2009535651A5 (en) | ||
KR101730288B1 (en) | Methods of electrochemically measuring an analyte with a test sequence having a pulsed dc block as well as devices, apparatuses and systems incorporating the same | |
JP2016510124A5 (en) | ||
EP3213059B1 (en) | Method for determining diffusion | |
CA2811851C (en) | Systems and methods of discriminating between a control sample and a test fluid using capacitance | |
Fujii et al. | Detection of direct electron transfer between a redox enzyme and an extended gold-gate using chemical CCD |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20170202 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: STEELE, DOMINIC Inventor name: DEAKIN, SHERINE Inventor name: LIU, ZUIFANG Inventor name: MCNEILAGE, ALAN |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1236623 Country of ref document: HK |
|
17Q | First examination report despatched |
Effective date: 20180524 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20200811 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1236623 Country of ref document: HK |